Recurrent thrombosis in antiphospholipid syndrome may be associated with cardiovascular risk factors and inflammatory response-Reference-Cited by-同舟云学术

Recurrent thrombosis in antiphospholipid syndrome may be associated with cardiovascular risk factors and inflammatory response

Published:2015-12 Issue:6 Volume:136 Page:1174-1178
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Saraiva Sabrina da Silva,Custódio Isadora Fernandes,Mazetto Bruna de Moraes,Collela Marina Pereira,de Paula Erich Vinícius,Appenzeller Simone,Annichino-Bizzachi Joyce,Orsi Fernanda Andrade^ORCID

Publisher

Elsevier BV

Subject

Hematology

Reference34 articles.

1. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients;Cervera;Arthritis Rheum.,2002

2. Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients;Cervera;Ann. Rheum. Dis.,2009

3. Thrombotic risk factors in primary antiphospholipid syndrome: a 5-year prospective study;Turiel;Stroke,2005

4. Antiphospholipid syndrome in northwest Italy (APS Piedmont Cohort): demographic features, risk factors, clinical and laboratory profile;Bertero;Lupus,2012

5. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome;Crowther;N. Engl. J. Med.,2003

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patients with antiphospholipid syndrome and a first venous or arterial thrombotic event: clinical characteristics, antibody profiles and estimate of the risk of recurrence;Clinical Chemistry and Laboratory Medicine (CCLM);2024-04-02

2. Risk factors and recurrent thrombosis in primary antiphospholipid syndrome;Exploration of Immunology;2023-10-12

3. Should we be targeting type 1 interferons in antiphospholipid syndrome?;Clinical Immunology;2023-10

4. Anticoagulantes de acción directa en el síndrome antifosfolípido. Revisión sistemática;Medicina Clínica;2023-07

5. Direct-acting oral anticoagulants in antiphospholipid syndrome: A systematic review;Medicina Clínica (English Edition);2023-07